Loading…
Hosted by Unknown Host · 🇺🇸 US · EN · 15 episodes
Established thought leaders with verified media credentials.
On Target: Targeting What Matters in Testing is a podcast dedicated to exploring the evolving landscape of diagnostics and its critical role in the development of precision healthcare. Testing is at the center of healthcare like never before, thanks to advancements in genomic sequencing, AI-driven diagnostics, biomarker-driven therapies, and home testing. Healthcare systems are adapting to integrate these technologies effectively, and regulators are trying to keep pace with innovation. Co-hosted by industry experts, On Target features conversations with testing company and laboratory executives, innovators, and thought leaders who are shaping the future of healthcare through testing products and services. In the time it takes to drink your coffee, we’ll let you know where the field is going next.
Unknown Host hosts On Target Podcast, a news show with 15 episodes published.
Bob Wassman, chief medical officer and executive vice president of clinical affairs at MARABio, explains how testing for maternal auto-antibodies can drive early autism diagnosis and treatment.
Suchi Saria, founder and CEO of Bayesian Health, tells us about her company's sepsis-detection system - and how to successfully bring such a system into the clinic.
Connie Lehman, founder and CEO of Clairity, shares how AI-driven insights can improve early detection, personalize screening, and ultimately change the future of breast-cancer care.
Madhuri Hegde, SVP and CSO of Revvity, discusses how her company leverages partnerships and broad expertise in both life sciences and diagnostics to solve patient problems.
Janet Woodcock, distinguished FDA veteran and past deputy commissioner of the agency, gives us her take on AI, companion diagnostics, drugs for rare diseases, and how to earn trust for new technology.
Janet Woodcock, distinguished FDA veteran and past deputy commissioner of the agency, gives us her take on AI, companion diagnostics, drugs for rare diseases, and how to earn trust for new technology.
Madhuri Hegde, SVP and CSO of Revvity, discusses how her company leverages partnerships and broad expertise in both life sciences and diagnostics to solve patient problems.
Connie Lehman, founder and CEO of Clairity, shares how AI-driven insights can improve early detection, personalize screening, and ultimately change the future of breast-cancer care.
Dawn Mattoon, CEO of Mercy Bioanalytics, explains how her company is using extracellular vesicles to successfully diagnose early stage cancer.
Doug Biehn, President and CEO of Octave Biosciences, talks about the difference that a biomarker test can make in the management of multiple sclerosis.
Alec Ford, CEO of Karius, shares how genomics and AI are expanding what's possible in infectious disease diagnostics — and why getting the right answer faster can make all the difference for immunocompromised patients ba
Irene Ghobrial, founder of Predicta Biosciences, explains how bringing whole-genome sequencing into the clinic is taking diagnosis and treatment of multiple myeloma and blood cancers to a new level of precision.
Alka Chaubey, CMO of Bionano Genomics, explains how optical genome mapping addresses the unmet needs of cytogenomics - and what it takes to get pathbreaking new technology into the clinic.
Susan Tousi, CEO of DELFI Diagnostics, shares how her company is using AI and fragmentomics to make liquid biopsy more accessible and cancer less deadly.
James Lu, co-founder and CEO of Helix, tells us what his company is doing to make genomics part of the standard portfolio of health-care data.
Julia Cheek, founder and CEO of Everlywell, shares how her company is working to change not only the way people access, use, and understand home tests, but the way home tests fit into the entire landscape of medicine.
Katherine Stueland, CEO of GeneDx, shares how her company is scaling whole-genome and exome sequencing for the diagnosis of rare diseases.
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
On Target Podcast has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their news audience.
On Target Podcast is hosted by Unknown Host. The show is categorised under news (health) and has published 15 episodes.
On Target Podcast has published 15 episodes.
On Target Podcast regularly covers news, health, fitness. It sits in the news category, with a health focus.
On Target Podcast is accessible for guests with genuine news expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
On Target Podcast hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of On Target Podcast average 31 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates On Target Podcast's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched yesterday.